HeartMate III is the next-generation continuous flow left ventricular assist device (:LVAD). It is based on fully magnetically levitated technology in order to reduce adverse event rates through ...

HeartMate III is a next-generation continuous flow left ventricular assist device (:LVAD) based on fully magnetically levitated technology. This technology helps in reducing adverse event rates ...

Manufacturer and marketer of medical devices used for mechanical circulatory support, Thoratec Corp.THOR, recently announced that the first HeartMate III implant has been conducted via ...

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it received final ...

LITTLE ROCK (KATV) — Arkansas' first HeartMate III was implanted this morning at Baptist Health Medical Center. First Baptist Transplant Institute is currently one of just 60 select centers chosen to ...

Please provide your email address to receive an email when new articles are posted on . Thoratec Corporation announced that it has received approval from the FDA to expand enrollment of the HeartMate ...

Thoratec Corp. ( THOR) shares rallied nearly 2.0% following the commencement of its HeartMate III U.S. clinical trial. The company revealed that it has begun enrolling patients for the U.S. trial, ...

St. Jude Medical landed European regulatory approval to introduce the HeartMate III left ventricular assist device for patients with heart failure that are waiting for a transplant, are not eligible ...

PLEASANTON, Calif., June 27, 2014 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing ...

FDA has granted Thoratec Corp. permission to enlarge its pivotal trial for the next-generation HeartMate III left ventricular assist system (LVAS). This gives the company the ability to enroll a ...

A surgical team in Toronto has successfully implanted a novel mechanical device, the HeartMate IIITM, into a patient with advanced heart failure. This is the first time this procedure has been ...

Thoratec shed almost one-third of its value after reporting abysmal second quarter earnings. The advanced heart failure device company attributed most of the miss to a New England Journal of Medicine ...